ACUTA CAPITAL PARTNERS, LLC Hedge Fund

CIK: 0001582844 · Show all filings

Period: Q4 2022 (← Previous) (Next →)

Filing Date: Feb 14, 2023

Total Value ($000): $162,501 (100.0% shares, 0.0% debt)

Holdings (34)

WHWK AADI BIOSCIENCES INC 12.1%
Value ($000) $19,622 Shares 1,849,402 Est. Cost $27.48 Unrealized -52.5%
VRDN VIRIDIAN THERAPEUTICS INC 7.1%
Value ($000) $11,582 Shares 396,500 Est. Cost $17.88 Unrealized +28.8%
APLS APELLIS PHARMACEUTICALS INC 6.9%
Value ($000) $11,247 Shares 217,500 Est. Cost $38.98 Unrealized +36.1%
TERN TERNS PHARMACEUTICALS INC 6.9%
Value ($000) $11,198 Shares 1,100,000 Est. Cost $5.72 Unrealized +16.4%
UTHR UNITED THERAPEUTICS CORP DEL 5.6%
Value ($000) $9,177 Shares 33,000 Est. Cost $220.39 Unrealized +14.5%
SRPT SAREPTA TEHRAPEUTICS INC 5.4%
Value ($000) $8,747 Shares 67,500 Est. Cost $106.61 Unrealized +8.7%
SNDX SYNDAX PHARMACEUTICALS INC 5.1%
Value ($000) $8,261 Shares 324,614 Est. Cost $19.57 Unrealized +19.2%
IVERIC BIO INC 4.7%
Value ($000) $7,718 Shares 360,500 Est. Cost $7.63 Unrealized
VTYX VENTYX BIOSCIENCES INC 4.7%
Value ($000) $7,558 Shares 290,500 Est. Cost $21.58 Unrealized +37.3%
PCVX VAXCYTE INC 4.3%
Value ($000) $6,929 Shares 144,500 Est. Cost $31.07 Unrealized +26.3%
CYMABAY THERAPEUTICS INC. COMMON STOCK 3.9%
Value ($000) $6,364 Shares 1,015,000 Est. Cost $6.27 Unrealized
KURA KURA ONCOLOGY INC. COMMON STOCK 3.8%
Value ($000) $6,224 Shares 501,500 Est. Cost $15.03 Unrealized -3.3%
MERSANA THERAPEUTICS INC 3.4%
Value ($000) $5,567 Shares 950,000 Est. Cost $5.86 Unrealized
BELLUS HEALTH INC 3.2%
Value ($000) $5,199 Shares 632,500 Est. Cost $8.20 Unrealized
CLDX CELLDEX THERAPEUTICS INC 3.2%
Value ($000) $5,126 Shares 115,000 Est. Cost $7.56 Unrealized +372.3%
RCKT ROCKET PHARMACEUTICALS INC 3.1%
Value ($000) $5,088 Shares 260,000 Est. Cost $18.42 Unrealized 0.0%
BCAB BIOATLA INC 2.5%
Value ($000) $4,125 Shares 500,000 Est. Cost $6.55 Unrealized +26.7%
ACRS ACLARIS THERAPEUTICS 2.5%
Value ($000) $4,016 Shares 255,000 Est. Cost $16.22 Unrealized -0.8%
KROS KEROS THERAPEUTICS INC 2.4%
Value ($000) $3,842 Shares 80,000 Est. Cost $46.71 Unrealized 0.0%
GHRS GH RESEARCH PLC 1.5%
Value ($000) $2,364 Shares 243,250 Est. Cost $20.48 Unrealized -47.2%
ARGX ARGEN SE 1.2%
Value ($000) $1,932 Shares 5,100 Est. Cost $378.83 Unrealized
ARWR ARROWHEAD PHARMACEUTICALS INC 1.0%
Value ($000) $1,664 Shares 41,029 Est. Cost $42.29 Unrealized -21.6%
FULC FULCRUM THERAPEUTICS INC 0.8%
Value ($000) $1,347 Shares 185,000 Est. Cost $11.30 Unrealized -42.3%
PMVP PMV PHARMACEUTICALS INC 0.8%
Value ($000) $1,344 Shares 154,471 Est. Cost $17.26 Unrealized -38.2%
EYPT EYEPOINT PHARMACEUTICALS INC 0.7%
Value ($000) $1,062 Shares 303,396 Est. Cost $11.19 Unrealized -60.6%
IOVA IOVANCE BIOTHERAPEUTICS INC 0.6%
Value ($000) $982 Shares 153,639 Est. Cost $19.89 Unrealized -60.8%
MLTX MOONLAKE IMMUNOTHERAPEUTICS 0.6%
Value ($000) $982 Shares 93,500 Est. Cost $8.89 Unrealized 0.0%
PYXS PYXIS ONCOLOGY INC 0.6%
Value ($000) $897 Shares 669,158 Est. Cost $5.29 Unrealized -71.6%
RZLT REZOLUTE INC 0.5%
Value ($000) $869 Shares 420,000 Est. Cost $3.32 Unrealized -43.7%
HORIZON THERAPEUTICS PLC 0.4%
Value ($000) $683 Shares 6,000 Est. Cost $106.80 Unrealized
PRTA PROTHENA CORPORATION PLC 0.3%
Value ($000) $560 Shares 9,300 Est. Cost $58.56 Unrealized 0.0%
IMARA INC 0.1%
Value ($000) $182 Shares 44,503 Est. Cost $4.09 Unrealized
KINNATE BIOPHARMA INC 0.0%
Value ($000) $31 Shares 5,000 Est. Cost $12.00 Unrealized
NUVATION BIO INC 0.0%
Value ($000) $13 Shares 90,832 Est. Cost $0.28 Unrealized